JPWO2020097588A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020097588A5
JPWO2020097588A5 JP2021524387A JP2021524387A JPWO2020097588A5 JP WO2020097588 A5 JPWO2020097588 A5 JP WO2020097588A5 JP 2021524387 A JP2021524387 A JP 2021524387A JP 2021524387 A JP2021524387 A JP 2021524387A JP WO2020097588 A5 JPWO2020097588 A5 JP WO2020097588A5
Authority
JP
Japan
Prior art keywords
host cell
cds
seq
cucurbitadienol
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021524387A
Other languages
Japanese (ja)
Other versions
JP2022507029A (en
JP7498708B2 (en
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/060652 external-priority patent/WO2020097588A1/en
Publication of JP2022507029A publication Critical patent/JP2022507029A/en
Publication of JPWO2020097588A5 publication Critical patent/JPWO2020097588A5/ja
Application granted granted Critical
Publication of JP7498708B2 publication Critical patent/JP7498708B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Claims (15)

ククルビタジエノールシンターゼ(CDS)酵素をコードする異種ポリヌクレオチドを含む宿主細胞であって、該異種ポリヌクレオチド配列が配列番号3と少なくとも90%同一であるおよび/または異種ポリヌクレオチドによりコードされるCDSのアミノ酸配列が配列番号43と少なくとも90%同一であり、そしてここで、該宿主細胞がククルビタジエノール化合物を産生する、宿主細胞。 A host cell comprising a heterologous polynucleotide encoding a cucurbitadienol synthase (CDS) enzyme, wherein the heterologous polynucleotide sequence is at least 90% identical to SEQ ID NO: 3 and/or the CDS encoded by the heterologous polynucleotide is at least 90% identical to SEQ ID NO: 43, and wherein said host cell produces a cucurbitadienol compound. 該CDSが配列番号73の123位のアミノ酸残基に対応するアミノ酸残基にロイシンを含む、請求項1に記載の宿主細胞。 2. The host cell of claim 1, wherein said CDS comprises a leucine at the amino acid residue corresponding to amino acid residue 123 of SEQ ID NO: 73 . 該CDS酵素が基質溝および活性部位腔を含む、請求項1または2に記載の宿主細胞。 3. The host cell of claim 1 or 2 , wherein said CDS enzyme comprises a substrate groove and an active site cavity. 該宿主細胞がUDP-グリコシルトランスフェラーゼ(UGT)、C11ヒドロキシラーゼ、シトクロムP450レダクターゼ、エポキシドヒドロラーゼ(EPH)、ラノステロールシンターゼ、および/またはスクアレンエポキシダーゼをコードする1以上の異種ポリヌクレオチドをさらに含む、請求項1-3のいずれか一項に記載の宿主細胞。 4. The host cell further comprises one or more heterologous polynucleotides encoding UDP-glycosyltransferase (UGT), C11 hydroxylase, cytochrome P450 reductase, epoxide hydrolase (EPH) , lanosterol synthase, and/or squalene epoxidase. The host cell according to any one of 1-3. 該宿主細胞が酵母細胞、植物細胞または細菌細胞である、請求項1-4のいずれか一項に記載の宿主細胞。A host cell according to any one of claims 1-4, wherein said host cell is a yeast cell, a plant cell or a bacterial cell. 該宿主細胞が、サッカロミセス細胞、所望によりサッカロミセス・セレビシエ細胞;ヤロウイア細胞、所望によりヤロウイア・リポリティカ細胞;または大腸菌細胞である、請求項5に記載の宿主細胞。6. A host cell according to claim 5, wherein said host cell is a Saccharomyces cell, optionally a Saccharomyces cerevisiae cell; a Yarrowia cell, optionally a Yarrowia lipolytica cell; or an E. coli cell. 該宿主細胞が対照に比して少なくとも10%、20%、または30%以上のククルビタジエノール化合物を生産し、ここで該対象が、配列番号33に対応するポリヌクレオチドによりコードされるラカンカCDSを発現する宿主細胞である、請求項1-6のいずれか一項に記載の宿主細胞。wherein said host cell produces at least 10%, 20%, or 30% or more of a cucurbitadienol compound relative to a control, wherein said subject is a swingle CDS encoded by a polynucleotide corresponding to SEQ ID NO:33; 7. The host cell of any one of claims 1-6, which is a host cell that expresses 該CDSがアミノ酸モチーフDQGWL(配列番号335)を含み、所望により該モチーフが、配列番号73における残基479-483に対応するCDSにおける残基に存在する、請求項1-7のいずれか一項に記載の宿主細胞。 8. Any one of claims 1-7, wherein said CDS comprises the amino acid motif DQGWL (SEQ ID NO:335), optionally said motif is present at residues in the CDS corresponding to residues 479-483 in SEQ ID NO:73. A host cell as described in . 該CDSが、アミノ酸モチーフGHWANDLGGP(配列番号336)を含み、所望により該モチーフが、配列番号73における残基117-126に対応するCDSにおける残基に存在する、請求項1-8のいずれか一項に記載の宿主細胞。9. Any one of claims 1-8, wherein the CDS comprises the amino acid motif GHWANDLGGP (SEQ ID NO:336), optionally wherein the motif is present at residues in the CDS corresponding to residues 117-126 in SEQ ID NO:73. A host cell according to paragraph. 該CDSが、アミノ酸モチーフCWGVCYTYAGW(配列番号337)を含み、所望により該モチーフが、配列番号73における残基612-622に対応するCDSにおける残基に存在する、請求項1-9のいずれか一項に記載の宿主細胞。10. Any one of claims 1-9, wherein the CDS comprises the amino acid motif CWGVCYTYAGW (SEQ ID NO:337), optionally wherein the motif is present at residues in the CDS corresponding to residues 612-622 in SEQ ID NO:73. A host cell according to paragraph. 該CDSのアミノ酸配列が配列番号43を含む、請求項1-10のいずれか一項に記載の宿主細胞。11. The host cell of any one of claims 1-10, wherein the amino acid sequence of said CDS comprises SEQ ID NO:43. 該宿主細胞が、ラノステロールシンターゼ(ERG7)を下方制御するようさらに修飾されている、請求項1-11のいずれか一項に記載の宿主細胞。12. The host cell of any one of claims 1-11, wherein said host cell is further modified to down-regulate lanosterol synthase (ERG7). 請求項1-12のいずれか一項に記載の宿主細胞とオキシドスクアレンを接触させ、所望によりククルビタジエノール化合物を単離し、それにより、ククルビタジエノール化合物を産生することを含む、ククルビタジエノール化合物を産生する方法。 13. A cucurbita comprising contacting the host cell of any one of claims 1-12 with oxidosqualene and optionally isolating the cucurbitadienol compound, thereby producing a cucurbitadienol compound. A method for producing a dienol compound. オキシドスクアレンが2-3-オキシドスクアレンまたは2,3;22,23-ジエポキシスクアレンである、請求項13に記載の方法。 14. The method of claim 13 , wherein the oxidosqualene is 2-3-oxidosqualene or 2,3;22,23-diepoxysqualene. ククルビタジエノール化合物が、11-ヒドロキシククルビタジエノール、24-25エポキシ-ククルビタジエノール、またはククルビタジエノールである、請求項13または14に記載の方法または請求項1-12のいずれか一項に記載の宿主細胞。The method of claim 13 or 14 or any of claims 1-12, wherein the cucurbitadienol compound is 11-hydroxy cucurbitadienol, 24-25 epoxy-cucurbitadienol, or cucurbitadienol. or the host cell of claim 1.
JP2021524387A 2018-11-09 2019-11-09 Mogroside biosynthesis Active JP7498708B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862758474P 2018-11-09 2018-11-09
US62/758,474 2018-11-09
PCT/US2019/060652 WO2020097588A1 (en) 2018-11-09 2019-11-09 Biosynthesis of mogrosides

Publications (3)

Publication Number Publication Date
JP2022507029A JP2022507029A (en) 2022-01-18
JPWO2020097588A5 true JPWO2020097588A5 (en) 2022-11-17
JP7498708B2 JP7498708B2 (en) 2024-06-12

Family

ID=70612318

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021524387A Active JP7498708B2 (en) 2018-11-09 2019-11-09 Mogroside biosynthesis

Country Status (6)

Country Link
US (1) US20210403921A1 (en)
EP (1) EP3877519A4 (en)
JP (1) JP7498708B2 (en)
CN (1) CN113302298A (en)
CA (1) CA3118924A1 (en)
WO (1) WO2020097588A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3177183A1 (en) * 2020-05-13 2021-11-18 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides
CN112063647B (en) * 2020-09-17 2023-05-02 云南农业大学 Construction method of saccharomyces cerevisiae recombinant Cuol01, saccharomyces cerevisiae recombinant Cuol02 and application
EP4314316A2 (en) * 2021-06-29 2024-02-07 Firmenich Incorporated Methods for making high intensity sweeteners
WO2023278226A1 (en) * 2021-06-29 2023-01-05 Firmenich Incorporated Mogroside compounds and their comestible use
CN113755355A (en) * 2021-09-30 2021-12-07 河北维达康生物科技有限公司 Engineering strain for biosynthesis of mogrol by taking glucose as substrate, construction and application thereof
CN114410492A (en) * 2021-12-24 2022-04-29 河北维达康生物科技有限公司 Engineering bacterium for biosynthesis of cucurbitadienol by taking glucose as substrate, construction and application thereof
CN114703159B (en) * 2022-03-15 2023-05-26 林影 Glycosyltransferase mutant and application thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2015536157A (en) * 2012-12-04 2015-12-21 エヴォルヴァ エスアー.Evolva Sa. Methods and materials for biosynthesis of mogroside compounds
CN104017798B (en) 2014-06-04 2016-08-24 中国医学科学院药用植物研究所 A kind of mutant of Momordica grosvenori SgCS gene and application thereof
SG11201702123SA (en) * 2014-10-01 2017-04-27 Evolva Sa Methods and materials for biosynthesis of mogroside compounds
CN105018438A (en) * 2015-07-13 2015-11-04 中国农业科学院蔬菜花卉研究所 Gene cluster participating in synthesis of muskmelon cucurbitacine B and application of gene cluster
BR112019023104A2 (en) * 2017-05-03 2020-11-03 Firmenich Incorporated methods for making high intensity sweetener
WO2021081327A1 (en) * 2019-10-25 2021-04-29 Ginkgo Bioworks, Inc. Biosynthesis of mogrosides

Similar Documents

Publication Publication Date Title
CN107466320B (en) Methods and materials for biosynthesizing mogroside compounds
JP2018511335A5 (en)
JP2019503657A5 (en)
JP2008530994A5 (en)
JP2018516600A5 (en)
JP2011515107A5 (en)
EP2451960A2 (en) Engineered microorganisms with enhanced fermentation activity
JP2015536157A (en) Methods and materials for biosynthesis of mogroside compounds
JPWO2020097588A5 (en)
KR101351879B1 (en) ethane―1,2-diol producing microorganism and a method for producinig ethane―1,2-diol using the same
CA2785276A1 (en) Xylose isomerase and use thereof
JP7117307B2 (en) Metnikavia species for biosynthesis of compounds
JP2010539910A (en) Method for enantioselective enzymatic reduction of intermediates
AU2013227067B2 (en) Hydrocarbon synthase gene, and use thereof
CN109468291B (en) Carbonyl reductase EbSDR8 mutant and construction method and application thereof
JP2020506722A5 (en)
EP3559208A1 (en) Method and organism expressing metschnikowia xylose transporters for increased xylose uptake
WO2014156476A1 (en) Genetically modified clostridium saccharoperbutylacetonicum
US20240150804A1 (en) Demethylation of Reticuline and Derivatives Thereof with Fungal Cytochrome P450
JPWO2016056610A1 (en) Method for producing 7 dehydrocholesterol and vitamin D3
Lyu et al. Overlapping promoter library designed for rational heterogenous expression in Cordyceps militaris
Saw et al. 4.2 Sustainability and Development of Industry 5.0
US11479796B2 (en) Method for production of sugar alcohol from red algae
JP2013021947A (en) Mutant yeast belonging to genus kluyveromyces and production method of ethanol using the same
US10982239B2 (en) Method for producing meso-galactaric acid by contacting a fungal cell with a biomaterial having galacturonic acid